Here's the live share price of Indoco Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Indoco Remedies has declined 8.27% CAGR. Over the past year, the corresponding return has been -39.32%.
Indoco Remedies’s current P/E of -17.34x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Indoco Remedies | -1.73 | -12.45 | -27.85 | -34.36 | -39.32 | -19.93 | -8.27 |
| Sun Pharmaceutical Industries | -5.32 | -9.10 | -4.74 | -4.82 | -8.61 | 15.33 | 22.53 |
| Divi's Laboratories | -5.54 | -7.79 | -8.93 | -10.25 | 3.20 | 21.04 | 10.74 |
| Torrent Pharmaceuticals | -1.24 | 3.69 | 10.16 | 12.22 | 25.25 | 35.31 | 23.63 |
| Cipla | -4.53 | -9.45 | -17.69 | -7.18 | -4.05 | 8.83 | 10.99 |
| Lupin | -2.49 | 0.67 | 10.14 | 11.39 | 1.76 | 40.87 | 14.91 |
| Dr. Reddy's Laboratories | -2.61 | -10.00 | -10.40 | -8.26 | -10.32 | 10.02 | 2.72 |
| Zydus Lifesciences | -1.01 | -4.69 | -12.48 | -9.76 | -11.22 | 25.40 | 13.27 |
| Mankind Pharma | -6.58 | -4.17 | -14.32 | -20.79 | -18.22 | 13.76 | 8.04 |
| Alkem Laboratories | -2.78 | 0.84 | 2.09 | 13.37 | 9.48 | 23.04 | 13.00 |
| Aurobindo Pharma | -4.33 | -7.76 | 2.56 | -0.81 | -4.85 | 36.32 | 4.58 |
| Biocon | -3.71 | -8.53 | -0.19 | -7.48 | -6.48 | 13.69 | -3.75 |
| Abbott India | -0.76 | -1.13 | -8.49 | -18.70 | 0.17 | 8.23 | 13.82 |
| Glenmark Pharmaceuticals | -3.26 | -4.54 | 4.86 | -10.88 | 29.75 | 66.88 | 31.35 |
| Laurus Labs | -9.38 | -7.02 | 7.02 | 19.21 | 71.39 | 41.60 | 21.72 |
| GlaxoSmithKline Pharmaceuticals | -4.30 | -9.25 | -17.09 | -26.54 | 6.90 | 21.47 | 8.53 |
| Ipca Laboratories | -3.04 | 3.08 | 14.70 | 0.25 | -4.76 | 18.99 | 7.43 |
| Ajanta Pharma | 0.05 | 0.22 | 10.34 | -2.47 | -4.41 | 31.26 | 18.41 |
| Anthem Biosciences | -4.59 | -12.74 | -19.96 | -18.67 | -18.67 | -6.66 | -4.05 |
| J B Chemicals & Pharmaceuticals | -0.64 | 4.12 | 11.21 | 11.70 | 4.63 | 24.06 | 30.10 |
Over the last one year, Indoco Remedies has declined 39.32% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (3.20%), Torrent Pharmaceuticals (25.25%). From a 5 year perspective, Indoco Remedies has underperformed peers relative to Sun Pharmaceutical Industries (22.53%) and Divi's Laboratories (10.74%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 215.8 | 216.17 |
| 10 | 221.13 | 219.52 |
| 20 | 227.87 | 225.99 |
| 50 | 244.46 | 241.59 |
| 100 | 265.43 | 256.5 |
| 200 | 271.28 | 270.07 |
In the latest quarter, Indoco Remedies remained same as its previous close in promoter holding, while DII stake decreased to 18.16%, FII holding rose to 1.25%, and public shareholding moved up to 21.60% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 41,99,230 | 0.33 | 98.51 | |
| 32,33,474 | 2.44 | 75.86 | |
| 25,94,559 | 0.09 | 60.87 | |
| 20,25,592 | 0.36 | 47.52 | |
| 18,34,924 | 0.52 | 43.05 | |
| 15,34,403 | 0.47 | 36 | |
| 4,62,465 | 0.4 | 10.85 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jan 20, 2026, 5:03 PM IST | Indoco Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Jan 16, 2026, 11:03 PM IST | Indoco Remedies - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations A |
| Jan 06, 2026, 11:40 PM IST | Indoco Remedies - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 11, 2025, 11:14 PM IST | Indoco Remedies - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 28, 2025, 10:10 PM IST | Indoco Remedies - Retirement Of Senior Management Personnel |
Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 1518.19 Cr. and Equity Capital is Rs. 18.45 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Indoco Remedies is ₹207.75 as on Jan 21, 2026.
The Indoco Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Indoco Remedies is ₹1,916.45 Cr as on Jan 21, 2026.
Today’s highest and lowest price of Indoco Remedies are ₹208.65 and ₹202.85.
The 52-week high/low is the highest and lowest price at which Indoco Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Indoco Remedies is ₹348.10 and 52-week low of Indoco Remedies is ₹190.00 as on Jan 21, 2026.
The Indoco Remedies has shown returns of -0.14% over the past day, -12.45% for the past month, -27.85% over 3 months, -39.32% over 1 year, -19.93% across 3 years, and -8.27% over 5 years.
P/E ratio of and PB ratio of Indoco Remedies are -17.34 and 1.96 on Jan 21, 2026. While the company gives a dividend yield of 0.10 per annum.